Regenera Pharma's Corporate Minority Round

Regenera Pharma raised a round of funding on , . Investors include Intercure.

Regenera Pharma is developing a drug for the treatment of degenerative nerve diseases. Its first product is designed to treat a rare disease called nonarteritic anterior ischemic optic neuropathy (NAI…

Articles about Regenera Pharma's Corporate Minority Round: